MO01.41 Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

Authors :: Janet K. Horton
K. Nikolov
M.D. Gómez
Davorin Radosavljevic
Iveta Kudaba
Rajesh K. Malik
Jie Xiao
Jana Jaal
Janakiraman Subramanian
T. Csőszi
Source :: Journal of Thoracic Oncology. 16:S33
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
In patient
Non small cell
business

Tools